| Accession Number | 0001632901-26-000010 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 2, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP & Chief Medical Officer | Common Stock | โ | Feb 27, 2026 | Sale | 2,345 | $499.71 | $1,171,819.95 | 409 | Indirect | by Trust | View Details | |
EVP & Chief Medical Officer | Common Stock | โ | Feb 28, 2026 | Exercise/Conversion | 1,002 | $0.00 | $0.00 | 1,411 | Indirect | by Trust | View Details | |
EVP & Chief Medical Officer | Common Stock | โ | Feb 28, 2026 | Tax Withholding | 497 | $503.51 | $250,244.47 | 914 | Indirect | by Trust | View Details | |
EVP & Chief Medical Officer | Common Stock | โ | Feb 28, 2026 | Exercise/Conversion | 8,378 | $0.00 | $0.00 | 9,292 | Indirect | by Trust | View Details | |
EVP & Chief Medical Officer | Common Stock | โ | Feb 28, 2026 | Tax Withholding | 4,155 | $503.51 | $2,092,084.05 | 5,137 | Indirect | by Trust | View Details | |
EVP & Chief Medical Officer | Performance Stock Units - 2-28-2023 | Derivative | Feb 28, 2026 | Exercise/Conversion | 8,378 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
EVP & Chief Medical Officer | Restricted Stock Units | Derivative | Feb 28, 2026 | Exercise/Conversion | 1,002 | $0.00 | $0.00 | 0 | Direct | โ | View Details |